椎体压迫骨折器械市场- 按产品类型（球囊椎体后凸成形术、椎体成形术）、手术（微创脊椎手术、开放性脊椎手术）、最终用途（医院、ASC、创伤中心） -全球预测2024 - 2032

在微创手术的兴起和技术进步的推动下，椎骨压缩骨折器材市场规模从 2024 年到 2032 年将以 7.8% 的复合CAGR成长。

椎体成形术和椎体后凸成形术等微创手术可减少椎体骨折患者的术后疼痛、恢復更快并缩短住院时间。这一趋势推动了对创新椎体压迫骨折 (VCF) 设备的需求，因为它们专为精确、安全和有效的治疗而设计。高黏度骨水泥、先进影像方式和导航工具等技术进步也提高了 VCF 手术的有效性和安全性。例如，2023 年 11 月，医学影像领域的知名领导者 ImageBiopsy Lab 推出了 IB Lab FLAMINGO，这是一种深度学习电脑模型，可在 CT 扫描中检测椎骨压迫性骨折。随着医疗保健提供者采用这些先进设备来改善患者的治疗效果，市场有望获得成长动力。

椎体压迫骨折器械产业分为产品类型、手术、最终用途和地区。

就产品类型而言，预计 2024 年至 2032 年椎体成形术领域的市场规模复合CAGR为 6.9%。椎体成形术是一种微创手术，涉及将骨水泥注射到骨折的椎骨以稳定和减轻疼痛。此外，技术进步正在为高黏度骨水泥和导航工具的开发让路。骨质疏鬆症相关椎体骨折盛行率的上升以及越来越多地采用椎体成形术来治疗疼痛将进一步推动该细分市场的成长。

就最终用途而言，门诊手术中心(ASC) 领域的椎体压缩骨折器械行业将在2023 年产生可观的收入，并预计在2032 年之前实现8.6% 的增长率。ASC 为传统医院提供高效且经济高效的替代方案VCF 治疗的设置。此外，ASC 对微创技术和快速恢復优势的关注与 VCF 治疗不断增长的需求一致。由于 ASC 的便利性、较短的等待时间以及包括椎体成形术和椎体后凸成形术在内的门诊手术的可用性，患者对 ASC 的偏好不断增加，这将促进该细分市场的增长

从地区来看，亚太地区椎体压缩骨折器械产业在2023 年拥有可观的收入，并且在人口老化不断扩大的推动下，到2032 年将呈现8.2% 的成长率，而老龄化人口更容易发生骨质疏鬆相关骨折。根据亚洲骨质疏鬆症协会联合会的数据，50岁以上的新加坡女性中有三分之一患有骨质疏鬆症。此外，研究预测，新加坡因骨质疏鬆症导致的骨折总数将从 2017 年的 15,267 例增加到 2035 年的 24,104 例，在不到 20 年的时间里激增 57.9%。人们对椎体压迫性骨折微创手术的认识不断提高，以及医疗保健支出的增加，将增强该地区的产业前景。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 骨质疏鬆症盛行率增加
    • 椎体压迫骨折装置的技术进步
    • 随着脊椎相关疾病患者数量的增加，认识程度不断提高
  • 产业陷阱与挑战
    • 设备成本高
    • 与术后併发症相关的风险
• 成长潜力分析
• 监管环境
• 技术景观
• 波特的分析
• PESTEL分析
• 未来市场趋势

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品类型，2018 年 - 2032 年

• 主要趋势
• 球囊椎体后凸成形术
• 椎体成形术

第 6 章：市场估计与预测：按手术分类，2018 - 2032 年

• 主要趋势
• 微创脊椎手术
• 开放性脊椎手术

第 7 章：市场估计与预测：按最终用途，2018 - 2032 年

• 主要趋势
• 医院
• 门诊手术中心
• 创伤中心
• 其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Becton, Dickinson and Company
• Boston Scientific Corporation
• IZI Medical Products
• Johnson & Johnson (DePuy Synthes)
• Medtronic Plc
• Merit Medical Systems Inc
• Spine Wave, Inc
• Spirit Spine Holdings Corporation Inc.
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.

Vertebral Compression Fracture Devices Market size is poised to expand at 7.8% CAGR from 2024 to 2032 driven by the rise in minimally invasive surgeries and technological advancements.

Minimally invasive procedures, such as vertebroplasty and kyphoplasty offer less post-operative pain, quicker recovery, and reduced hospital stays for patients with vertebral fractures. This trend is driving the demand for innovative vertebral compression fracture (VCF) devices as they are designed for precise, safe, and effective treatment. Technological advancements, such as high-viscosity bone cement, advanced imaging modalities, and navigational tools are also enhancing the efficacy and safety of VCF procedures. For instance, in November 2023, ImageBiopsy Lab, an established leader in medical imaging, launched IB Lab FLAMINGO, a deep-learning computer model that can detect vertebral compression fractures in CT scans. With healthcare providers adopting these advanced devices to improve patient outcomes, the market is poised to gain momentum.

The vertebral compression fracture devices industry is segmented into product type, surgery, end-use, and region.

With respect to product type, the market size from the vertebroplasty segment is projected to witness 6.9% CAGR from 2024-2032. Vertebroplasty is a minimally invasive procedure that involves the injection of bone cement into fractured vertebrae to stabilize and alleviate pain. Furthermore, technological advancements are making way for the development of high-viscosity bone cement and navigational tools. The rising prevalence of osteoporosis-related vertebral fractures and the increasing adoption of vertebroplasty for pain management will further propel the segment growth.

In terms of end-use, the vertebral compression fracture devices industry from the ambulatory surgical centers (ASCs) segment generated substantial revenue in 2023 and is poised to record 8.6% growth rate through 2032. ASCs offer efficient and cost-effective alternatives to traditional hospital settings for VCF treatments.. Additionally, the focus of ASCs' on minimally invasive techniques and rapid recovery benefits aligns with the rising demand for VCF treatments. The increasing patient preference for ASCs due to their convenience, shorter wait times, and availability of outpatient procedures including vertebroplasty and kyphoplasty will boost segment growth

Regionally, the Asia Pacific vertebral compression fracture devices industry held a sizable revenue in 2023 and is set to exhibit 8.2% growth rate through 2032 driven by the expanding aging population, which is more susceptible to osteoporosis-related fractures. According to the Asian Federation of Osteoporosis Societies, one-third of Singaporean women aged above 50 years have osteoporosis. Furthermore, studies predict that the overall number of fractures caused by osteoporosis in Singapore will rise from 15,267 in 2017 to 24,104 in 2035, representing a 57.9% spike in less than 20 years. Rising awareness about minimally invasive procedures for vertebral compression fractures, and increasing healthcare expenditure will augment the regional industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of osteoporosis
    • 3.2.1.2 Technological advancements vertebral compression fracture devices
    • 3.2.1.3 Rising awareness levels coupled with growing patient population of spine related disorders
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of devices
    • 3.2.2.2 Risk associated with post-surgical complications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis
• 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Balloon kyphoplasty
• 5.3 Vertebroplasty

Chapter 6 Market Estimates and Forecast, By Surgery, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Minimally invasive spine surgery
• 6.3 Open spine surgery

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Trauma centers
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Becton, Dickinson and Company
• 9.2 Boston Scientific Corporation
• 9.3 IZI Medical Products
• 9.4 Johnson & Johnson (DePuy Synthes)
• 9.5 Medtronic Plc
• 9.6 Merit Medical Systems Inc
• 9.7 Spine Wave, Inc
• 9.8 Spirit Spine Holdings Corporation Inc.
• 9.9 Stryker Corporation
• 9.10 Zimmer Biomet Holdings, Inc.